Establishing a Decision-Making Threshold for PIVKA II in the Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC): A Single Centre Experience. [PDF]
Farina A +5 more
europepmc +1 more source
Clinical value of serum AFP and PIVKA-II for diagnosis, treatment and prognosis of hepatocellular carcinoma. [PDF]
Tian S, Chen Y, Zhang Y, Xu X.
europepmc +1 more source
68Ga-FAPI-04 PET/CT in the Diagnosis of Hepatocellular Carcinoma Associated with Cirrhosis: Diagnostic Value, Correlation Between PET Parameters of the Tumor and Its Size, and PIVKA-II Levels. [PDF]
Zholdybay Z +8 more
europepmc +1 more source
[A case of PIVKA-II and AFP producing gastric carcinoma].
INOUE, Toru +9 more
openaire +2 more sources
Immunohistochemical study of PIVKA-II in hepatocellular carcinoma.
NADANO, Seijin +5 more
openaire +2 more sources
Erratum: Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma [Corrigendum]. [PDF]
europepmc +1 more source
Immunohistochemical study for PIVKA-II in hepatocellular carcinoma.
NOUNO, Ryuichi +6 more
openaire +2 more sources
Plasma PIVKA-II levels in hepatobiliary disease.
SUZUKI, Yuichi +5 more
openaire +2 more sources
S, Fujiyama +4 more
openaire +3 more sources
Analysis of the optimal patterns of serum alpha fetoprotein (AFP), AFP-L3% and protein induced by vitamin K absence or antagonist-II (PIVKA-II) detection in the diagnosis of liver cancers. [PDF]
Luo L +7 more
europepmc +1 more source

